Latest Articles — Page 96 of 501

Physicians’ and patients’ opinions on the use of generic drugs

Antoni Sicras-Mainar, Ruth Navarro-Artieda

Volume 3, Issue 3 · pp. 268–270 · 2012

MicroRNAs as newer therapeutic targets: A big hope from a tiny player

Hardik S. Ghelani, Manish A. Rachchh, Rina H. Gokani

Volume 3, Issue 3 · pp. 217–227 · 2012

Metformin ameliorates methotrexate-induced hepatotoxicity

Najah R. Hadi, Fadhil G. Al-Amran, Asma Swadi

Volume 3, Issue 3 · pp. 248–253 · 2012

A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospital

Kingshuk Lahon, Harsha M Shetty, Amith Paramel, Gyaneshwar Sharma

Volume 3, Issue 3 · pp. 266–268 · 2012

Impact of clinical pharmacist interventions on the cost of drug therapy in intensive care units of a tertiary care teaching hospital

Jisha M. Lucca, M. Ramesh, Gopalakrishna M. Narahari, N. Minaz

Volume 3, Issue 3 · pp. 242–247 · 2012

Docetaxel-induced hand foot syndrome: “No dose is a safe dose”

Ankit Jain, Biswajit Dubashi

Volume 3, Issue 2 · pp. 200–201 · 2012

Chronotherapy in hypertension

Volume 3, Issue 2 · pp. 209–209 · 2012

Carbamazepine-induced erythema multiforme major in an epileptic patient with bipolar affective disorder

Suneet K. Upadhyaya, Rangeel S. Raina, Archana Sharma, Vijay Thawani, Deepak Dimari

Volume 3, Issue 2 · pp. 202–204 · 2012

Is gripe water baby-friendly?

B. Adhisivam

Volume 3, Issue 2 · pp. 207–8 · 2012

Induction of cell-specific apoptosis and protection of mice from cancer challenge by a steroid positive compound from Zornia diphylla (L.) Pers

R. Arunkumar, S. Ajikumaran Nair, A. Subramoniam

Volume 3, Issue 3 · pp. 233–241 · 2012

Clinical trial ethics in India: One step forward, two steps back

Anant Bhan

Volume 3, Issue 2 · pp. 95–97 · 2012

Pharmacotherapy for multidrug resistant tuberculosis

Naveen Chhabra, M. L. Aseri, Ramakant Dixit, S. Gaur

Volume 3, Issue 2 · pp. 98–104 · 2012